Advertisement
Advertisement
KPRX
Kiora Pharmaceuticals, Inc. Common Stock
2.59
USDSponsored
-0.01
-0.38%
Jun 24, 16:00 UTC -4
Closed
Pre-Market
2.50
-0.09
-3.44%
KPRX Earnings Reports
Positive Surprise Ratio
KPRX beat 25 of 40 last estimates.
63%
Next Report
Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.63
Implied change from Q1 26 (Revenue/ EPS)
--
/+10.53%
Implied change from Q2 25 (Revenue/ EPS)
--
/+16.67%
Kiora Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On May 08, 2026, KPRX reported earnings of -0.57 USD per share (EPS) for Q1 26, beating the estimate of -0.72 USD, resulting in a 19.91% surprise. Revenue reached --, compared to an expected 1.53 million, with a -100.00% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.63 USD, with revenue projected to reach -- USD, implying an increase of 10.53% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Kiora Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Kiora Pharmaceuticals, Inc. Common Stock reported EPS of -$0.57, beating estimates by 19.91%, and revenue of $0.00, -100% below expectations.
How did the market react to Kiora Pharmaceuticals, Inc. Common Stock's Q1 2026 earnings?
The stock price moved -- 0%, changed from $2.45 before the earnings release to $2.45 the day after.
When is Kiora Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 06, 2026.
What are the forecasts for Kiora Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 3
analysts, Kiora Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.63 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement